Unknown

Dataset Information

0

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.

ABSTRACT:

SUBMITTER: Spencer EA 

PROVIDER: S-EPMC8499751 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.

Spencer Elizabeth A EA   Klang Eyal E   Dolinger Michael M   Pittman Nanci N   Dubinsky Marla C MC  

Inflammatory bowel diseases 20211001 11

Similar Datasets

Unknown Seroconversion among rituximab-treated patients following SARS-CoV-2 vaccine supplemental dose.
| S-EPMC9547394 | biostudies-literature
Unknown Humoral Immune Response Following SARS-CoV-2 mRNA Vaccination and Infection in Pediatric-Onset Multiple Sclerosis.
| S-EPMC9979636 | biostudies-literature
Unknown Humoral profiling of pediatric patients with cancer reveals robust immunity following anti-SARS-CoV-2 vaccination superior to natural infection.
| S-EPMC10321888 | biostudies-literature
Unknown Conception and reality: Outcome of SARS-CoV-2 infection and vaccination among Hungarian IBD patients on biologic treatments.
| S-EPMC9773695 | biostudies-literature
Unknown Waning immunity to SARS-CoV-2 following vaccination or infection.
| S-EPMC9606629 | biostudies-literature
Unknown SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity.
| S-EPMC9624106 | biostudies-literature
Unknown SARS-CoV-2 vaccination in IBD: more pros than cons.
| S-EPMC7816748 | biostudies-literature
Unknown Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
| S-EPMC8188741 | biostudies-literature
Unknown Comparison of SARS-CoV-2 Hyperimmune Immunoglobulins Following Infection Plus Vaccination vs Infection.
| S-EPMC10403779 | biostudies-literature
Unknown Adverse events following immunization and psychological distress among cancer patients/survivors following vaccination against SARS-CoV-2 infection.
| S-EPMC9360916 | biostudies-literature